• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白细胞介素-8 通过下调乳腺癌细胞中的 Mir-200 家族促进上皮间质转化。

Interleukin-8 Promotes Epithelial-to-Mesenchymal Transition via Downregulation of Mir-200 Family in Breast Cancer Cells.

机构信息

Breast Disease Center, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China.

Department of Anesthesiology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China.

出版信息

Technol Cancer Res Treat. 2020 Jan-Dec;19:1533033820979672. doi: 10.1177/1533033820979672.

DOI:10.1177/1533033820979672
PMID:33280520
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7724258/
Abstract

The microRNA-200 (miR-200) family has been reported to be vital for the inhibition of epithelial-to-mesenchymal transition (EMT) in tumor cells. The miR-200 family represents a complex multi-factorial regulatory network which has not been well described in breast cancer. This study aimed to clarify the underlying regulatory association between IL-8 and miR-200 family in the process of EMT in breast cancer cell. In estrogen-receptor (ER) positive breast cancer cell line MCF-7, IL-8 overexpression cells were performed by lentivirus transfection as endogenous regulation with additional exogenous IL-8 stimulation. Transient overexpressions of miR-200 family were performed after endogenous or exogenous IL-8 overexpression in MCF-7 cells. IL-8 knockdown cells were constructed via siRNA and shRNA transfection in triple negative breast cancer cell line MDA-MB-231. N-cadherin, vimentin and ZEB2 were down-regulated and E-cadherin was up-regulated in IL-8 knockdown group compared with control group. On the other hand, N-cadherin, vimentin and ZEB2 were up-regulated and E-cadherin was down-regulated in IL-8 overexpression group compared with control group. This indicated IL-8 promotes EMT in breast cancer cells. Transwell assay showed that IL-8 increased the migration and invasiveness of tumor cells. Furthermore, we performed transient overexpression of miR-200 family after endogenous or exogenous IL-8 overexpression in MCF-7 cells, which showed that the miR-200 family could inhibit EMT induced by IL-8. IL-8 promoted EMT via downregulation of miR-200 family expression in breast cancer cells and increases tumor cell migration and invasion.

摘要

miR-200 家族在肿瘤细胞上皮间质转化(EMT)的抑制中起着至关重要的作用。miR-200 家族代表了一个复杂的多因素调控网络,在乳腺癌中尚未得到很好的描述。本研究旨在阐明 IL-8 与乳腺癌细胞 EMT 过程中 miR-200 家族之间的潜在调控关系。在雌激素受体(ER)阳性乳腺癌细胞系 MCF-7 中,通过慢病毒转染过表达 IL-8 作为内源性调节,并进行额外的外源性 IL-8 刺激。在 MCF-7 细胞中过表达内源性或外源性 IL-8 后,进行 miR-200 家族的瞬时过表达。在三阴性乳腺癌细胞系 MDA-MB-231 中,通过 siRNA 和 shRNA 转染构建 IL-8 敲低细胞。与对照组相比,IL-8 敲低组中 N-钙粘蛋白、波形蛋白和 ZEB2 下调,E-钙粘蛋白上调。另一方面,与对照组相比,IL-8 过表达组中 N-钙粘蛋白、波形蛋白和 ZEB2 上调,E-钙粘蛋白下调。这表明 IL-8 促进乳腺癌细胞 EMT。Transwell 实验表明,IL-8 增加了肿瘤细胞的迁移和侵袭能力。此外,我们在 MCF-7 细胞中过表达内源性或外源性 IL-8 后进行 miR-200 家族的瞬时过表达,结果表明 miR-200 家族可以抑制 IL-8 诱导的 EMT。IL-8 通过下调 miR-200 家族的表达促进乳腺癌细胞 EMT,并增加肿瘤细胞的迁移和侵袭。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ea2/7724258/4a7842019a64/10.1177_1533033820979672-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ea2/7724258/e654770e4ff8/10.1177_1533033820979672-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ea2/7724258/7c2ba6b8f8f7/10.1177_1533033820979672-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ea2/7724258/dec3045d90fa/10.1177_1533033820979672-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ea2/7724258/4a7842019a64/10.1177_1533033820979672-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ea2/7724258/e654770e4ff8/10.1177_1533033820979672-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ea2/7724258/7c2ba6b8f8f7/10.1177_1533033820979672-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ea2/7724258/dec3045d90fa/10.1177_1533033820979672-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ea2/7724258/4a7842019a64/10.1177_1533033820979672-fig4.jpg

相似文献

1
Interleukin-8 Promotes Epithelial-to-Mesenchymal Transition via Downregulation of Mir-200 Family in Breast Cancer Cells.白细胞介素-8 通过下调乳腺癌细胞中的 Mir-200 家族促进上皮间质转化。
Technol Cancer Res Treat. 2020 Jan-Dec;19:1533033820979672. doi: 10.1177/1533033820979672.
2
MicroRNA-520c-3p negatively regulates EMT by targeting IL-8 to suppress the invasion and migration of breast cancer.微小 RNA-520c-3p 通过靶向白细胞介素-8 抑制 EMT 来负调控乳腺癌的侵袭和迁移。
Oncol Rep. 2017 Nov;38(5):3144-3152. doi: 10.3892/or.2017.5968. Epub 2017 Sep 19.
3
Molecular mechanism of miR-153 inhibiting migration, invasion and epithelial-mesenchymal transition of breast cancer by regulating transforming growth factor beta (TGF-β) signaling pathway.miR-153 通过调控转化生长因子 β(TGF-β)信号通路抑制乳腺癌迁移、侵袭及上皮间质转化的分子机制。
J Cell Biochem. 2019 Jun;120(6):9539-9546. doi: 10.1002/jcb.28230. Epub 2018 Dec 7.
4
miR-448 inhibits the epithelial-mesenchymal transition in breast cancer cells by directly targeting the E-cadherin repressor ZEB1/2.miR-448 通过直接靶向 E-钙黏蛋白抑制因子 ZEB1/2 抑制乳腺癌细胞的上皮-间充质转化。
Exp Biol Med (Maywood). 2018 Mar;243(5):473-480. doi: 10.1177/1535370218754848. Epub 2018 Jan 25.
5
53BP1 suppresses epithelial-mesenchymal transition by downregulating ZEB1 through microRNA-200b/429 in breast cancer.在乳腺癌中,53BP1通过微小RNA-200b/429下调ZEB1来抑制上皮-间质转化。
Cancer Sci. 2015 Aug;106(8):982-9. doi: 10.1111/cas.12699. Epub 2015 Jul 14.
6
MicroRNA-133a inhibits gastric cancer cells growth, migration, and epithelial-mesenchymal transition process by targeting presenilin 1.MicroRNA-133a 通过靶向早老素 1 抑制胃癌细胞的生长、迁移和上皮-间充质转化过程。
J Cell Biochem. 2019 Jan;120(1):470-480. doi: 10.1002/jcb.27403. Epub 2018 Aug 30.
7
MicroRNA-548m Suppresses Cell Migration and Invasion by Targeting Aryl Hydrocarbon Receptor in Breast Cancer Cells.微小 RNA-548m 通过靶向乳腺癌细胞中的芳香烃受体抑制细胞迁移和侵袭。
Oncol Res. 2021 Mar 16;28(6):615-629. doi: 10.3727/096504020X16037933185170. Epub 2020 Oct 27.
8
microRNA-335 inhibits colorectal cancer HCT116 cells growth and epithelial-mesenchymal transition (EMT) process by targeting Twist1.微小RNA-335通过靶向Twist1抑制结直肠癌HCT116细胞的生长和上皮-间质转化(EMT)过程。
Pharmazie. 2017 Aug 1;72(8):475-481. doi: 10.1691/ph.2017.7489.
9
miR-381 inhibited breast cancer cells proliferation, epithelial-to-mesenchymal transition and metastasis by targeting CXCR4.miR-381 通过靶向 CXCR4 抑制乳腺癌细胞增殖、上皮间质转化和转移。
Biomed Pharmacother. 2017 Feb;86:426-433. doi: 10.1016/j.biopha.2016.12.051. Epub 2016 Dec 21.
10
miR-203 Acts as an Inhibitor for Epithelial-Mesenchymal Transition Process in Diabetic Foot Ulcers via Targeting Interleukin-8.miR-203 通过靶向白细胞介素-8 作用于糖尿病足溃疡的上皮间质转化过程。
Neuroimmunomodulation. 2019;26(5):239-249. doi: 10.1159/000503087. Epub 2019 Nov 8.

引用本文的文献

1
Non-coding RNAs, a double-edged sword in breast cancer prognosis.非编码RNA,乳腺癌预后中的一把双刃剑。
Cancer Cell Int. 2025 Apr 1;25(1):123. doi: 10.1186/s12935-025-03679-0.
2
Triptolide suppresses IL-1β-induced expression of interleukin-8 by inhibiting ROS-Mediated ERK, AP-1, and NF-κB molecules in human gastric cancer AGS cells.雷公藤甲素通过抑制人胃癌AGS细胞中活性氧介导的细胞外信号调节激酶、活化蛋白-1和核因子-κB分子,抑制白细胞介素-1β诱导的白细胞介素-8表达。
Front Oncol. 2025 Jan 30;14:1498213. doi: 10.3389/fonc.2024.1498213. eCollection 2024.
3
The signature of extracellular vesicles in hypoxic breast cancer and their therapeutic engineering.

本文引用的文献

1
20()-Protopanaxadiol Inhibits Angiotensin II-Induced Epithelial- Mesenchymal Transition by Downregulating SIRT1.20(S)-原人参二醇通过下调SIRT1抑制血管紧张素II诱导的上皮-间质转化
Front Pharmacol. 2019 May 7;10:475. doi: 10.3389/fphar.2019.00475. eCollection 2019.
2
Interleukin-8 upregulates integrin β3 expression and promotes estrogen receptor-negative breast cancer cell invasion by activating the PI3K/Akt/NF-κB pathway.白细胞介素-8 通过激活 PI3K/Akt/NF-κB 通路上调整合素 β3 表达并促进雌激素受体阴性乳腺癌细胞侵袭。
Cancer Lett. 2015 Aug 10;364(2):165-72. doi: 10.1016/j.canlet.2015.05.009. Epub 2015 May 12.
3
缺氧乳腺癌中外泌体的特征及其治疗工程。
Cell Commun Signal. 2024 Oct 21;22(1):512. doi: 10.1186/s12964-024-01870-w.
4
Jagged/Notch proteins promote endothelial-mesenchymal transition-mediated pulmonary arterial hypertension via upregulation of the expression of GATAs.锯齿蛋白/Notch 蛋白通过上调 GATA 表达促进内皮-间充质转化介导的肺动脉高压。
J Cell Mol Med. 2023 Apr;27(8):1110-1130. doi: 10.1111/jcmm.17723. Epub 2023 Mar 20.
5
Cytokines and microRNAs in SARS-CoV-2: What do we know?严重急性呼吸综合征冠状病毒2中的细胞因子和微小RNA:我们了解什么?
Mol Ther Nucleic Acids. 2022 Sep 13;29:219-242. doi: 10.1016/j.omtn.2022.06.017. Epub 2022 Jun 25.
6
The association of immunosurveillance and distant metastases in colorectal cancer.结直肠癌中的免疫监视与远处转移的关联。
J Cancer Res Clin Oncol. 2021 Nov;147(11):3333-3341. doi: 10.1007/s00432-021-03753-w. Epub 2021 Sep 2.
7
miR-940 is a new biomarker with tumor diagnostic and prognostic value.微小RNA-940是一种具有肿瘤诊断和预后价值的新型生物标志物。
Mol Ther Nucleic Acids. 2021 May 8;25:53-66. doi: 10.1016/j.omtn.2021.05.003. eCollection 2021 Sep 3.
The microRNA-200 family--a potential diagnostic marker in hepatocellular carcinoma?
微小 RNA-200 家族——肝细胞癌的潜在诊断标志物?
J Surg Oncol. 2014 Sep;110(4):430-8. doi: 10.1002/jso.23668. Epub 2014 Jun 4.
4
Epithelial plasticity: a common theme in embryonic and cancer cells.上皮细胞可塑性:胚胎细胞和癌细胞中的共同主题。
Science. 2013 Nov 8;342(6159):1234850. doi: 10.1126/science.1234850.
5
Epithelial-mesenchymal plasticity in carcinoma metastasis.癌转移中的上皮-间充质可塑性。
Genes Dev. 2013 Oct 15;27(20):2192-206. doi: 10.1101/gad.225334.113.
6
Tumour angiogenesis regulation by the miR-200 family.miR-200 家族对肿瘤血管生成的调控。
Nat Commun. 2013;4:2427. doi: 10.1038/ncomms3427.
7
An immunohistochemical study of interleukin-8 (IL-8) in breast cancer.乳腺癌中白细胞介素-8(IL-8)的免疫组织化学研究。
Acta Histochem. 2012 Oct;114(6):571-6. doi: 10.1016/j.acthis.2011.10.007. Epub 2012 Jan 11.
8
Loss of miR-200 inhibition of Suz12 leads to polycomb-mediated repression required for the formation and maintenance of cancer stem cells.miR-200 抑制 Suz12 的丧失导致多梳介导的抑制,这是癌症干细胞形成和维持所必需的。
Mol Cell. 2010 Sep 10;39(5):761-72. doi: 10.1016/j.molcel.2010.08.013.
9
Loss of miR-200c expression induces an aggressive, invasive, and chemoresistant phenotype in non-small cell lung cancer.miR-200c 表达缺失导致非小细胞肺癌中侵袭性、耐药表型的产生。
Mol Cancer Res. 2010 Sep;8(9):1207-16. doi: 10.1158/1541-7786.MCR-10-0052. Epub 2010 Aug 9.
10
Loss of miR-200c: A Marker of Aggressiveness and Chemoresistance in Female Reproductive Cancers.miR-200c 缺失:女性生殖系统癌症侵袭性和化疗耐药的一个标志物。
J Oncol. 2010;2010:821717. doi: 10.1155/2010/821717. Epub 2009 Dec 15.